Pharmacophore Analysis and Molecular Docking Simulations to Design G Protein-coupled Receptors Antagonists with Ligand Selectivity
Nagy, M., Kishk, S., darwish, K., Mostafa, S., Salama, I. (2025). Pharmacophore Analysis and Molecular Docking Simulations to Design G Protein-coupled Receptors Antagonists with Ligand Selectivity. EKB Journal Management System, 9(1), 77-83. doi: 10.21608/rpbs.2025.386310.1374
Manar Nagy; Safaa Kishk; khaled darwish; Samia M Mostafa; Ismail Salama. "Pharmacophore Analysis and Molecular Docking Simulations to Design G Protein-coupled Receptors Antagonists with Ligand Selectivity". EKB Journal Management System, 9, 1, 2025, 77-83. doi: 10.21608/rpbs.2025.386310.1374
Nagy, M., Kishk, S., darwish, K., Mostafa, S., Salama, I. (2025). 'Pharmacophore Analysis and Molecular Docking Simulations to Design G Protein-coupled Receptors Antagonists with Ligand Selectivity', EKB Journal Management System, 9(1), pp. 77-83. doi: 10.21608/rpbs.2025.386310.1374
Nagy, M., Kishk, S., darwish, K., Mostafa, S., Salama, I. Pharmacophore Analysis and Molecular Docking Simulations to Design G Protein-coupled Receptors Antagonists with Ligand Selectivity. EKB Journal Management System, 2025; 9(1): 77-83. doi: 10.21608/rpbs.2025.386310.1374

Pharmacophore Analysis and Molecular Docking Simulations to Design G Protein-coupled Receptors Antagonists with Ligand Selectivity

Records of Pharmaceutical and Biomedical Sciences
Volume 9, Issue 1, March 2025, Page 77-83  XML PDF (970.1 K)
Document Type: Mini-reviews
DOI: 10.21608/rpbs.2025.386310.1374
View on SCiNiTO View on SCiNiTO
Authors
Manar Nagy email 1; Safaa Kishkorcid 2; khaled darwish1; Samia M Mostafa3; Ismail Salama4
1Pharmaceutical Medicinal Chemistry, Faculty of Pharmacy, Suez Canal University
2a. Medicinal Chemistry Department, Faculty of Pharmacy, Suez Canal University, Ismailia, Egypt b. School of Pharmacy & Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue, Cardiff CF10 3NB, UK
3Medicinal Chemistry Department, Suez Canal University, Faculty of Pharmacy, Ismailia, Egypt
4Faculty of Pharmacy - Suez Canal University
Abstract
Cancer development is closely associated and connected with immunosuppressive tumor microenvironment (TME) that attenuates antitumor immune responses and promotes tumor cell immunologic escape. The sequential conversion of extracellular Adenosine TriPhosphate (ATP) into adenosine by two important cell-surface ectonucleosides CD39 and CD73 plays a very critical role in reshaping the immunosuppressive TME. The accumulated extracellular adenosine mediates its regulatory functions by binding to one of four adenosine receptors (A1R, A2AR, A2BR and A3R). Adenosine emerges as a promising target for cancer therapy down to its protumor activities by inducing tumor cell proliferation, angiogenesis, chemo-resistance, and migration/invasion. Inhibition of the adenosine pathway alone or in combination with classic immunotherapies offers a potentially effective therapeutic strategy in cancer. Herein, computer-aided drug design approaches including pharmacophore analysis and molecular docking studies were adopted to examine the predicted binding modes for suggested A2A receptor antagonists to obtain a greater insight in SAR analyses and chemical examination.
Keywords
Adenosine; A2A receptors; pharmacophore; docking
Statistics
Article View: 57
PDF Download: 41